About the Company
We do not have any company description for Armata Pharmaceuticals, Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. (ARMP) - Yahoo Finance
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for ...
Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Armata Pharmaceuticals, Inc. (ARMP) one of those stocks right now? Let's take a ...
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.65 per share a year ago.
Armata Pharmaceuticals Announces Clearance of Investigational New Drug ...
Barring worsening COVID-19 conditions, Armata expects to initiate the SAD cohort by the end of this year. About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals Strengthens Clinical Team with Appointment of Dr ...
MARINA DEL REY, Calif., Oct. 16, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted ...
Armata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces First ...
As of May 8, 2025, approximately 36.2 million common shares were outstanding. About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Tops ... - Nasdaq
Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.25 per share a year ago.
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue ...
Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.69 per share a year ago.
ARMP - Armata Pharmaceuticals Inc Dividends | Morningstar
Review the current Armata Pharmaceuticals Inc (ARMP:XASE) dividend yield and history to decide if ARMP is the best investment for you.
TG1M - Armata Pharmaceuticals Inc Dividends | Morningstar
Armata Pharmaceuticals Inc TG1M Stock XSTU Rating as of Dec 20, 2024 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends Ownership ...
Similar Companies
Loading the latest forecasts...